Investor Relations

Event Details

Tumor Targeted Lymphocytes Summit

Dec 11 - Dec 13, 2018

Presenter: Dr. Gerrit Dispersyn, President and Chief Operating Officer
Title: Therapeutic Enhancement of TILs with Self-Delivering RNAi through Targeted Gene Silencing
Date and time: Thursday, December 13, 2018, at 12:10pm ET

Supporting Materials


Hilton Boston Back Bay, Boston, Massachusetts